• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$2.04 $0.03 (1.50%)

REAL-TIME: Last trade at

CAS MEDICAL SYSTEMS, INC.

NASDAQ:CASM

Jump to this page for:

Related Resources

CASMED Announces Significant Presence at Two Scientific Meetings

5/1/2012 by GlobeNewswire

CASMED to Announce First Quarter 2012 Financial Results and Hold Conference Call on May 8, 2012

4/30/2012 by GlobeNewswire

5 Stocks Under $10 Poised to Move Higher

4/5/2012 by TheStreet.com

CASMED Announces Publication in Congestive Heart Failure Journal of Study Demonstrating Value of FORE-SIGHT to Measure Cerebral Oxygenation

4/4/2012 by GlobeNewswire

CASMED to Present at 24th Annual ROTH Conference

3/7/2012 by GlobeNewswire

CAS Medical Systems (CASM) Q4 Loss Widens to $0.15

3/6/2012 by StreetInsider.com

CASMED Announces Fourth Quarter and Full Year 2011 Financial Results

3/6/2012 by GlobeNewswire

CORRECTION -- CASMED to Announce Fourth Quarter Financial Results and Hold Conference Call on March 6, 2012

2/28/2012 by GlobeNewswire

CASMED to Announce Fourth Quarter Financial Results and Hold Conference Call on March 6, 2012

2/28/2012 by GlobeNewswire

Morning Movers (ATPG, LNG, CTB, CASM, DNDN)

2/27/2012 by 24/7 Wall Street

CASMed's FORE-SIGHT Oximeter gains FDA clearance for neonatal abdomen use

2/27/2012 by Theflyonthewall.com

CASMED's FORE-SIGHT(R) Absolute Tissue Oximeter Gains FDA Clearance for Use on Neonatal Abdomen

2/27/2012 by GlobeNewswire

CAS Medical Systems Inc. (CASM) CEO Thomas M Patton buys 45,826 Shares

11/22/2011 by GuruFocus

CASMED Reports Q3 2011 Results

11/8/2011 by GlobeNewswire

CASMED Announces Third Quarter 2011 Earnings Release Date and Conference Call Information

11/1/2011 by GlobeNewswire

CAS Medical says study shows FORE-SIGHT provides superior accuracy

10/27/2011 by Theflyonthewall.com

New Study Shows Superior Accuracy of FORE-SIGHT Oximetry

10/27/2011 by GlobeNewswire

Thomas, McNerney & Partners lowers stake in CAS Medical to 28.1% from 39.1%

9/6/2011 by Theflyonthewall.com

CASMED to Present at the Rodman & Renshaw 13th Annual Healthcare Conference

9/1/2011 by GlobeNewswire

CAS Medical Systems (CASM) Files 6.24M Common Shelf for Selling Shareholders

8/30/2011 by StreetInsider.com

CAS Medical to host special shareholder meeting

8/16/2011 by Theflyonthewall.com

CAS Medical Systems Inc. Reports Operating Results (10-Q)

8/12/2011 by GuruFocus

CAS Medical Systems, Inc. (CASM) Reports Q2 Loss of $0.11; Revs Light

8/10/2011 by StreetInsider.com

CASMED Reports Q2 2011 Results

8/10/2011 by GlobeNewswire

CASMED Announces Second Quarter 2011 Earnings Release Date and Conference Call Information

8/3/2011 by GlobeNewswire

CASMED Announces Addition of Two Key Sales Executives

7/28/2011 by GlobeNewswire

CAS Medical and Medline announce distribution partnership

6/16/2011 by Theflyonthewall.com

Medline and CASMED Announce Distribution Partnership for Co-Branded Vital Signs Monitors

6/16/2011 by Marketwire

Medline and CASMED Announce Distribution Partnership for Co-Branded Vital Signs Monitors

6/15/2011 by StockWatch

CAS Medical raises $15M in private placement

6/9/2011 by Theflyonthewall.com

CASMED Raises $15 Million in Private Placement

6/9/2011 by GlobeNewswire

CAS Medical Systems Inc. Reports Operating Results (10-Q)

5/11/2011 by GuruFocus

CAS Medical Systems (CASM) Posts Wider Q1 Loss; Revs Light

5/11/2011 by StreetInsider.com

CASMED Reports Q1 2011 Results

5/11/2011 by GlobeNewswire

CASMED Announces First Quarter 2011 Earnings Release Date and Conference Call Information

5/4/2011 by GlobeNewswire

CASMED Reports Fourth Quarter and Full Year 2010 Results

3/2/2011 by GlobeNewswire

CASMED Announces Fourth Quarter and Year-End 2010 Earnings Release Date and Conference Call Information

2/23/2011 by GlobeNewswire

CAS Medical (CASM) Receives FDA Approval for FORE-SIGHT Expanded Labeling

1/18/2011 by StreetInsider.com

C A S Medical Systems gets 510K clearance to expand FORE-SIGHT labeling

1/18/2011 by Theflyonthewall.com

CASMED Receives FDA Clearance for Non-Cerebral Indication of FORE-SIGHT Absolute Tissue Oximeter

1/18/2011 by GlobeNewswire
See More Articles...